Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: Incidence and associated factor

Once-daily regimens containing DRV/RTV is associated with a higher rate of adverse cutaneous reactions than other PI-containing regimens in HIV-infected Taiwanese, especially in those who have a history of rashes to nNRTI-containing regimens before switch to DRV/RTV-containing regimens.